BioSante Pharmaceuticals, Inc. (BPAX)

[surf1944]

Small cap biotech companies are not in the business to buy their own stock back, so the likelihood of this for BPAX is near zero. BPAX will also likely complete the R/S if the stock is trading well below a dollar in the coming months. Again, over the long term the R/S should have little effect on the PPS since it is already reflected in the shares price. The current stock price will reflect the pipeline & its potential as the company goes forward.